U.S. researchers were able to repair stroke-related brain damage in mice without causing tumors after transplanting nerve cells developed from embryonic stem cells. The embryonic stem cells were induced to evolve into neuronal brain cells with the use of a transcription factor known as MEFC2. The findings could prove useful in treating stroke patients and people with Parkinson's and Alzheimer's diseases.

Related Summaries